Loading
No insider purchase over the last 90 days. The latest was filed 19 May 2023.
CNO Financial Group, Inc.: what insiders have been doing
CNO Financial Group, Inc., founded in 1979, is a Banks company based in Indianapolis. Its directors and officers file their transactions with SEC (Form 4). The last twelve months, up to 18 October 2026, brought 71 filings signed by 22 insiders.
There is no open-market purchase to report; the filings show 15 sales worth €4.9M by 4 insiders. No amount is published for 5 filings, which the totals therefore leave out. One trade stands out by size: a sale of €1.7M from Bhojwani Gary C, disclosed on 18 February 2026.
The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For context, the typical company on the same exchange (median of 5,811 companies) published 19 filings over the same period, against 71 filings here. Over the whole record (from 2021), the tally stands at 1 purchase and 72 sales. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 4.49 bn USD and net income at 229.3 m USD, and the dividend at 0.67 USD per share.
Other companies in the same sector with recent insider buying flagged by our signals: First Guaranty Bancshares, Inc. and BCB Bancorp Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
310
Thresholds
n/a
Buy Volume
€173,064
1 ops. · all time
Sell Volume
€17M
72 ops. · all time
Who traded when
BuySaleGary C. Bhojwani5 sales
Rocco F. Tarasi III4 sales
Jeremy D. Williams3 sales
Bhojwani Gary C2 sales
Franzese Yvonne K2 sales
Franzese Yvonne K.2 sales
+5 other insiders
Analyst consensus: bullish or bearish?
Analysts rate CNO Financial Group, Inc. Hold (neutral), based on 4 analysts. Average price target: US$54.75.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,501 of 24,158 companies
58.9
score / 100
Value70
Quality48
FCF yld13%
Earn yld4.5%
EV/EBITDA9.2x
ROE11%
Gross mgn·
Net mgn5.1%
Debt/EBITDA4.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$53.55
Analyst consensus
4 analystsHold
US$52.00Target US$54.75(+2%)US$57.00
Income statement
RevenueUS$4.5B
EBITDAUS$989.9M22% margin
Net incomeUS$229.3M6.0% margin
Valuation
PER (trailing)18.5x
PER (forward)10.6x
P/Book1.9x
Beta0.81
Balance sheet & cash
Market capUS$5B
Total debtUS$4.1B
Free Cash FlowUS$675.7M
Debt / Equity176%
Profitability & ownership
ROE10.9%
ROA1.1%
% insiders2.4%
% institutions98.1%
Last declaration on 16 September 2026
Declarations310 total
4,362 shares@ US$55.71520.0048% mcap49.9% of flowCommonSEC144:0001950047-26-009586
4,420 shares@ US$55.26960.0048% mcap26.2% of flowCommon StockSEC:0002006641-26-000010:1
4,420 shares@ US$21.060.0018% mcap10.0% of flowCommon StockSEC:0002006641-26-000010:0
3,240 shares@ US$23.330.0015% mcap8.1% of flowCommon StockSEC:0002006641-26-000010:2
3,240 shares@ US$55.71380.0036% mcap19.4% of flowCommon StockSEC:0002006641-26-000010:3
1,122 shares@ US$55.71920.0012% mcap6.7% of flowCommon StockSEC:0002006641-26-000010:4
4,420 shares@ US$55.26960.0048% mcap50.1% of flowCommonSEC144:0001950047-26-009484
6,560 shares@ US$54.98710.0071% mcap100.0% of flowCommonSEC144:0001950047-26-008850
9,374 shares@ US$54.97830.010% mcap100.0% of flowCommonSEC144:0001950047-26-008851
1,891 shares@ US$51.310.0019% mcap100.0% of flowCommonSEC144:0001950047-26-006698
44,250 sharesCommon StockSEC:0001614708-26-000014:0
44,250 sharesCommon StockSEC:0001614708-26-000014:1
41,798 sharesCommon StockSEC:0001614708-26-000014:2
1,891 sharesCommon StockSEC:0001571578-26-000011:0
86,048 shares@ US$51.47660.088% mcap100.0% of flowCommonSEC144:0001950047-26-006640
5,750 shares@ US$50.000.0057% mcap42.6% of flowCommonSEC144:0001950047-26-005921
3,308 sharesCommon StockSEC:0001571578-26-000009:0
5,750 sharesCommon StockSEC:0001571578-26-000009:1
5,750 sharesCommon StockSEC:0001571578-26-000009:2
3,308 shares@ US$49.000.0033% mcap24.1% of flowCommonSEC144:0001950047-26-005898
396 shares@ US$47.120.0003% mcap0.2% of flowCommon StockSEC:0001740471-26-000010:0
4,808 shares@ US$47.000.0040% mcap23.2% of flowCommon StockSEC:0001571578-26-000007:0
51,720 shares@ US$45.9977100.0% of flowCommonSEC144:0001243116-26-000001
4,808 shares@ US$47.000.0045% mcap33.3% of flowCommonSEC144:0001950047-26-005521
3,574 shares@ US$46.170.0032% mcap33.0% of flowCommon StockSEC:0001224608-26-000055:0
25 of 310 declarations
About CNO Financial Group, Inc.
CNO Financial Group, Inc. (NYSE: CNO) is a U.S.-listed insurance and financial services company headquartered in Carmel, Indiana, United States. For French-speaking investors, CNO is best understood as a specialty insurer focused on helping protect the financial future of middle-income Americans, especially pre-retirees and retirees. The company has built a multi-brand platform over time and today operates primarily through Bankers Life, Colonial Penn, Optavise, and Washington National, giving it exposure across several adjacent insurance and workforce-benefits niches.
CNO’s business model is centered on life insurance, health insurance, annuities, financial services, and workforce benefits solutions. Rather than competing as a broad-based mass-market insurer, the group concentrates on customer segments where advice, product design, persistence, and distribution relationships matter. Its operating footprint is national in scope, with offices in more than 220 communities across the United States. That breadth matters commercially: CNO can support direct, agent-driven, and partner-based distribution while maintaining a strong local presence in its core markets.
Read moreShow less
Each brand serves a distinct role. Bankers Life is positioned toward pre-retiree and retiree customers and is associated with life, health, annuity, and retirement-related offerings. Colonial Penn is widely recognized for consumer-oriented life insurance products. Optavise expands CNO’s worksite and employee-benefits capabilities, while Washington National adds capability in supplemental health, income protection, and related protection products. This brand architecture helps CNO address different customer needs without diluting its core specialty in middle-income protection.
From a competitive standpoint, CNO is not trying to be the largest insurer in the United States. Its edge lies in specialization, distribution reach, and product relevance to a clearly defined demographic. The company also emphasizes capital discipline and balance-sheet strength, and it highlights investment-grade ratings from major agencies. For investors, the key analytical questions are the durability of sales momentum, underwriting discipline, sensitivity to interest rates and investment income, and the company’s ability to convert sales into sustainable profitability and shareholder returns.
Recent developments have reinforced that profile. On February 5, 2026, CNO reported full-year 2025 results and said it exceeded most guidance metrics, with strong sales momentum and record annualized premium growth. On February 11, 2026, the board declared a quarterly dividend of $0.17 per share. The company also continued capital returns through share repurchases. These actions suggest management remains focused on earnings growth, capital efficiency, and shareholder remuneration. In market terms, CNO is an insurance name listed on the NYSE in the United States, offering targeted exposure to life, health, and retirement protection demand.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
